FBR Analyst Comments on Skirmish Between Express Scripts (ESRX) and Horizon Pharma (HZNP)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - Mizuho
November 11, 2015 11:57 AM ESTMizuho Securities analyst Irina Koffler reiterated a Buy rating and $34 price target on Horizon Pharma (NASDAQ: HZNP), saying they expect minimal impact from Linden disruption.
Koffler commented, "We spoke with management and learned that Linden processes ~150-200 prescriptions for Duexis, Vimovo, Pennsaid, and... More
DepoMed (DEPO) Sell-Off on Horizon News a 'Buying Opportunity'- Janney
November 11, 2015 11:48 AM ESTJanney Capital analyst Ken Trbovich reiterated a Buy rating and $35 fair value target on DepoMed Inc (NASDAQ: DEPO) calling today's sell-off on bad Horizon Pharma (NASDAQ: HZNP) a "buying opportunity."
Trbovich commented, "Today's sell off is completely... More
Insys Therapeutics (INSY) Trades Lower in Sympathy with Horizon Pharma (HZNP)
November 11, 2015 9:25 AM ESTInsys Therapeutics (NASDAQ: INSY) shares traded lower in sympathy with Horizon... More
Horizon Pharma (HZNP) Responds to Express Scripts' (ESRX) Lawsuit; Says Linden Care Isn't So-Called 'Captive Pharmacy'
November 11, 2015 6:42 AM ESTHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts (NASDAQ: ESRX) and recent allegations:
Our primary concern is for the patients who, based on the profit driven actions of Express Scripts, may be denied access to medicines that are prescribed by their physicians. We are committed to ensuring that regardless of these actions,... More
